ClusterOS Diagnostic Profile
Baltimore & Maryland Life Sciences & BioTech
Baltimore & Maryland Life Sciences & BioTech exhibits 7 observable stalls with Coordinating instead of deciding and Mediating instead of coupling as primary behavioural patterns. 5 stabilisation stacks identified.
Mediating (institutional intermediaries: TEDCO, commercialization offices, incubators) creates infrastructure through which Re-proving X-side (multiple validation pathways) operates. Repeated validation across intermediary types may sustain intermediary proliferation; intermediary presence may normalize multi-stage validation. Both operate in overlapping institutional space (, , appear in both stalls).
Coordinating (partnership formation across university-pharma-accelerator networks) may sustain Mediating (intermediary infrastructure) by creating demand for coordination services. Mediating (intermediaries) may sustain Coordinating by providing venues and mechanisms for partnership formation ( incubators, commercialization offices facilitate , partnerships).
Stabilising (institutional longevity, funding concentration in established actors) may sustain Mediating (intermediary infrastructure) if intermediaries preferentially connect to incumbents with established credibility ( Johns Hopkins funding concentration, university commercialization offices). Mediating (intermediaries) may sustain Stabilising by channeling resources through established...
Re-proving (multiple validation pathways) may sustain Stabilising (concentration around established actors) if validation mechanisms preferentially certify incumbents or if incumbents control validation infrastructure. Stabilising (incumbent concentration) may sustain Re-proving by creating multiple institutional checkpoints that new actors must navigate (, federal agencies; academic...
Narrating (cultural narrative construction, ) may sustain Scaling activity (activity scaling, , ) by providing legitimating story for program expansion. Scaling activity (workforce programs, sector scale metrics) may sustain Narrating by providing quantitative referents for narrative claims about ecosystem vitality.
"If instances where direct university-pharma coupling occurred without intermediary involvement were made systematically visible (publication, case documentation), it might reduce perceived necessity of intermediary validation for partnership...
Leverage hypotheses are testable perturbations, not prescriptions. Where demand-side behaviour is weakly visible, the correct move is observation — improving visibility before attempting change.
A full ClusterOS diagnostic adds actor questionnaire data, working sessions, and anchor interviews — producing higher-confidence stall identification, board-ready stack analysis, and leverage hypotheses calibrated to your specific context.